Flat worm

Not Applicable

Paragonimiasis is a food-borne parasitic infection caused by the lung fluke, most commonly Paragonimus westermani. It infects an estimated 22 million people yearly worldwide. It is particularly common in East Asia.

Western-Blot

Special Test

No patient preparation necessary.

Red or Gold Tube

3 mL Serum

Not Applicable

24 Hours

7 Days 

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Quantity Not sufficient
• Improperly labeled specimen
• Markedly lipemic sample

Batch Running

Tuesday and Friday, 12:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Q: What is Paragonimus?

A: Paragonimusis a parasitic lung fluke (flat worm). Cases of illness from infection occur after a person eats raw or undercooked infected crab or crayfish. The illness is known as paragonimiasis. Paragonimus is infection also can be very serious if the fluke travels to the central nervous system, where it can cause symptoms of meningitis.

Q: Where is Paragonimus found?

A:Paragonimus westermani and several other species are found throughout eastern, southwestern, and southeast Asia; (including China, the Philippines, Japan, Vietnam, South Korea, Taiwan, and Thailand). P. africanus is found in Africa, and P. mexicanus in Central and South America. There are several species of Paragonimus in other parts of the world that can infect humans. P. kellicotti is found in the midwestern and southern United States living in crayfish. Some human cases of infection have been associated with eating raw crayfish on river raft trips in the Midwest. Paragonimus has caused illness after ingestion of raw freshwater crabs.

Q: How is Paragonimus transmitted?

A:The infection is transmitted by eating infected crab or crawfish that is either, raw, partially cooked, pickled, or salted. The larval stages of the parasite are released when the crab or crawfish is digested. They then migrate within the body, most often ending up in the lungs. In 6-10 weeks the larvae mature into adult flukes.

Not Applicable.

• Fifth disease - IgG/IgM serology
• B19 - IgG/IgM serology
• Erythrovirus B19 - IgG/IgM serology
• Erythema infectiosum

Not applicable

Human parvovirus infects erythropoietic stem cells and causes erythema infectiosum (also called fifth disease), an epidemic disease, mainly affecting children, which is characterized by fever and rash. In certain individuals (usually those with some abnormality affecting either their hemoglobin or their red blood cell membrane), infection with human parvovirus can lead to acute hemolysis. Infected adults often experience inflammation of multiple joints which can last a matter of weeks.

Chemiluminescence

Special Test

No patient preparation necessary.

Red or Gold Tube

3 mL Serum

Not Applicable

4 Days

7 Days

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch Running

Friday, 4:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Not applicable

Parvovirus; Parvo B19, Parvovirus B19, Parvoviridae taxonomic

DNA Paternity Test

Not Applicable

To establish biological relationship between father and child.

DNA Analysis

Special Test

• Hardcopy of RTPCR negative results for BOTH PARTIES are needed 2-3 days from the date of collection.
• Inform Special Test Section before the scheduled sample collection for the collection kit.
• Request DNA Collection Kit to Special test section 3 days prior of swab collection.
• Only trained doctors/RMTs are allowed to collect samples.

Sample collection/handling:

1. Each collection kit (provided by HP Main Lab) includes 4 swabs.
2. Collect sample using the 4 swabs for each patient (i.e. 4 swabs for father, 4 swabs for child)
3. Return swabs to its sterile package and place it inside the provided envelope.
4. Encircle whether sample came from father or child.                 NOTE:Sample from father and child must be placed in separate envelopes.
5. Completely fill up the required information in the envelope.      NOTE:Signatures of patient and collector is required. For minors, legal guardian must sign on the envelope containing the child's sample.
6. Remove adhesive cover and seal the envelope with sample.
7. Send sample immediately to HP Main Lab.

Document Requirements:

• Birth Certificate/School I.D of child, actual and  2 photocopies
• Valid I.D of father, actual and  2 photocopies
• Completely filled up request form
• Completely filled up disclaimer form
• Mother's consent; Valid ID of mother, actual and 2 photocopies
• Valid ID of requesting party (if not the alleged father), actual and 2 photocopies

NOTE:Double check completeness and correctness of information before sending to HP Main Lab to avoid delay ing processing of sample.

DNA Collection kit(provided by Special Test)

4 swabs each from father and child

Not Applicable

7 Days

Not Applicable

Not Applicable

Transport specimen at 15°C ~25 °C (room temperature)

 

• Incomplete details of patient, including signatures
• Unlabelled sample
• Incorrect collection container used
• Incomplete document requirement

Batch Running

Friday, 12:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Not Applicable

None Specified.

Not Applicable

DNA test that establishes whether a man is the biological father of a child

DNA Paternity Test

Not Applicable

To establish biological relationship between alleged father and child.

DNA Analysis

Special Test

• Hardcopy of RTPCR negative results for BOTH PARTIES are needed 2-3 days from the date of collection.
• Inform Special Test Section before the scheduled sample collection for the collection kit.
• Request DNA Collection Kit to Special test section 3 days prior of swab collection.
• Only trained doctors/RMTs are allowed to collect samples.

Sample collection/handling:

1. Each collection kit (provided by HP Main Lab) includes 4 swabs.
2. Collect sample using the 4 swabs for each patient (i.e. 4 swabs for father, 4 swabs for child)
3. Return swabs to its sterile package and place it inside the provided envelope.
4. Encircle whether sample came from father or child.                 NOTE:Sample from father and child must be placed in separate envelopes.
5. Completely fill up the required information in the envelope.      NOTE:Signatures of patient and collector is required. For minors, legal guardian must sign on the envelope containing the child's sample.
6. Remove adhesive cover and seal the envelope with sample.
7. Send sample immediately to HP Main Lab.

Document Requirements:

• Birth Certificate/School I.D of child, actual and  2 photocopies
• Valid I.D of father, actual and  2 photocopies
• Completely filled up request form
• Completely filled up disclaimer form
• Mother's consent; Valid ID of mother, actual and 2 photocopies
• Valid ID of requesting party (if not the alleged father), actual and 2 photocopies

NOTE:Double check completeness and correctness of information before sending to HP Main Lab to avoid delay ing processing of sample.

DNA Swab Collection Kit - 4 swabs each(Provided by Special Test)

4 swabs each from father and child

Not Applicable

7 Days

Not Applicable

Not Applicable

Transport specimen at 15°C ~25 °C (room temperature)

 

• Incomplete details of patient, including signatures
• Unlabelled sample
• Incorrect collection container used
• Incomplete document requirement

Batch Running

Friday, 12:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Not Applicable

None Specified.

Not Applicable

DNA test that establishes whether a man is the biological father of a child

Not applicable

1. Total Testosterone
2. Free testosterone
3. Unconjugated DHEA
4. Androstenedione

• Useful for diagnosis and management of Polycystic Ovary Syndrome (PCOS)
• This panel measures both the primary (free and total Testosterone) and secondary (Androstenedione and DHEA) androgens associated with PCOS

Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)

Special Test

No patient preparation necessary.

Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator)

4 mL Serum

Not Applicable

72 Hours

7 Days

30 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch Running

Monday, 12:00 PM

14 days after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Not applicable

Androgens

Not applicable

1. Macroscopic
2. Microscopic
3. Differential Count
4. Pericardial Fluid Glucose
5. Pericardial Fluid Protein

• Cell Count and Differential Count: Cell count and identification of types of cells present are used in determining the cause of an effusion, especially when used in combination with an individual's medical history, physical examination and other tests performed.
• Body Fluid Protein and Glucose: Differentiates Transudates from Exudates. It helps identify the cause of fluid accumulation.

• WBC count- Fluorescent Cytometry
• RBC count- Hydrodynamic Focusing
• Differential Count- Fluorescence Cytometry/ Microscopic Examination
• Body Fluid Protein - Colorimetric (Biuret)
• Body Fluid Glucose - Enzymatic Colorimetric(Hexokinase)

• Cell Count/Differential Count: Hematology
• Body Fluid Protein and Glucose: Chemistry

• Cell Count/Diff Count: No patient preparation necessary
• Protein and Glucose: Preferably 8 hours fasting
• Send to Laboratory within 24 hours of collection.

Glucose and Protein:
• Bottle #1 placed on a plain tube (Red Top with no additive)

Cell Count/Diff Count:
• Bottle #2 placed on an EDTA Tube

• Cell Count/Diff Count: 3-5 mL
• Glucose and Protein: 3-5 mL

Not applicable

Glucose and Protein: 1 Day

Cell Count/Diff Count: 1 Day

Glucose and Protein: 6 Days

Cell Count/Diff Count: Not specified

Unacceptable

Transport specimen at 15–25 °C (room temperature)

• Quantity not sufficient
• Clotted sample (for Cell Count and Diff Count)
• Incorrect storage temperature of specimen
• Incorrect collection tube used
• Specimen stored exceeded required sample stability
• Highly viscous specimen
• Hemolyzed samples

Daily

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

ROUTINE
• 4 hours after receipt of specimen/ arrival of messenger
STAT
• After 2½ hours from extraction/messenger arrival

Glucose:
Transudate: Approximates whole blood levels
Exudate: Lower than whole blood levels

None specified

Not applicable

Pleural Fluid Analysis, Peritoneal Fluid Analysis, Gram Stain, Susceptibility Testing, Total Protein, Albumin, Glucose, AFB Testing, LD

• Blood smear test
• Erythrocyte Morphology
• Red Blood Cell Morphology (Blood)                                                                         •Blood Film                                                                                                                     •Manual Differential                                                                                                •Differential Slide                                                                                                            •Leukocyte Differential

Not applicable

Used to look for abnormalities in blood cells. The main blood cells that focuses on the Red blood cells (RBC), White blood cells (WBC) and Platelets. This test provides information on the number and shape of these cells, which can help doctors to diagnose certain blood disorders and other medical condition.

Direct Microscopic Examination

Hematology

• No patient preparation necessary.
 

• EDTA (purple top)
• Slides should be placed in slide holders or mailers before placing in a packaging container
• In cases wherein slide mailers/ holders are not available, place slides in a hard cardboard to prevent breakage

2 mL whole blood, 1 stained blood smear(wright-giemsa) and

1 unstained blood smear (Fixed with methanol)

Not applicable

Not applicable

Whole blood: 24 Hours

Not applicable

• Blood: Transport at 2ºC - 10ºC (with ice pack)
• Slides: Transport at 15ºC - 25ºC (room temp)

·       Improper collection of tubes

·       Specimen stored/transported outside the temperature range

·       Quantity not sufficient

·       Improperly labeled specimen

·      Markedly lipemic sample

Daily

Not applicable

2 days after specimen arrival/collection (excluding Saturdays, Sundays and Holidays)

INTERPRETATIVE REPORT

It is released as descriptive report that includes morphological assessment of various cells and estimation of quantity and proportion of blood cells

Whole blood sample exceeded stability

Q: What does the test result mean?

A: Blood smear results are not always diagnostic in themselves and more often indicate the possibility or presence of underlying condition, its severity, and the need of further testing. Clinical correlation is needed, as the results are taken into consideration with the results of the CBC and other laboratory tests, in addition to the tested person’s clinical signs and symptoms. It is best interpreted by your physician.

Peripheral Smear; Blood film, Manual differential slide, Red Blood Cell Morphology; Erythrocyte Morphology; Leukocyte Differential, Peripheral Blood Smear, Complete Blood Count, CBC,White Blood Cell Count (WBC) Differential, Platelet Count, Reticulocytes, Hemoglobinopathy Evaluation, Bone Marrow Aspiration and Biopsy, Anemia, Sickle Cell Anemia, Thalassemia, Hemoglobin Abnormalities, Leukemia, Malaria, Vitamin B12 and Folate Deficiencies, Bone Marrow Disorders.

Ascitic Fluid Analysis

1. Macroscopic
2. Microscopic
3. Differential Count
4. Peritoneal Glucose
5. Peritoneal Fluid Protein

• Cell Count and Differential Count: Cell count and identification of types of cells present are used in determining the cause of an effusion, especially when used in combination with an individual's medical history, physical examination and other tests performed.
• Body Fluid Protein and Glucose: Differentiates Transudates from Exudates. It helps identify the cause of fluid accumulation.

• WBC count- Fluorescent Cytometry
• RBC count- Hydrodynamic Focusing
• Differential Count- Fluorescence Cytometry/ Microscopic Examination
• Body Fluid Protein - Colorimetric (Biuret)
• Body Fluid Glucose - Enzymatic Colorimetric(Hexokinase)

• Cell Count/Differential Count: Hematology
• Body Fluid Protein and Glucose: Chemistry

• Cell Count/Diff Count: No patient preparation necessary
• Protein and Glucose: Preferably 8 hours fasting
• Send to Laboratory within 24 hours of collection.

Glucose and Protein:
• Bottle #1 placed on a plain tube (Red Top with no additive)

Cell Count/Diff Count:
• Bottle #2 placed on an EDTA Tube

• Cell Count/Diff Count: 3-5 mL
• Glucose and Protein: 3-5 mL

Not applicable

Glucose and Protein: 1 Day

Cell Count/Diff Count: 1 Day

Glucose and Protein: 6 Days

Cell Count/Diff Count: Not specified

Unacceptable

Transport specimen at 15–25 °C (room temperature)

• Quantity not sufficient
• Clotted sample (for Cell Count and Diff Count)
• Incorrect storage temperature of specimen
• Incorrect collection tube used
• Specimen stored exceeded required sample stability
• Highly viscous specimen
• Hemolyzed samples

Daily

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

ROUTINE
• 4 hours after receipt of specimen/ arrival of messenger
STAT
• After 2½ hours from extraction/messenger arrival

Glucose:
Transudate: 3.30~6.10 mmol/L
Exudate: Lower than whole blood levels

Total Protein:
Transudate: <25.00 g/L
Exudate: >30.00 g/L

Specific Gravity:
Transudate: <1.016
Exudate: >/=1.016

White Blood Cells:
Transudate: <100.00 x 10^3/uL
Exudate: >1000.00 x 10^3/uL

None specified

Not applicable

Pleural Fluid Analysis, Pericardial Fluid Analysis, Gram Stain, Susceptibility Testing, Glucose Tests, Albumin, White Blood Cell Count, Red Blood Cell Count, AFB Testing, Lactate Dehydrogenase (LD), Adenosine Deaminase

PHADEBACT CSF Test

Not applicable

Direct identification of capsular antigens of the following organisms:

• Streptococcus pneumonia
• Haemophilus influenza type b
• Neisseria meningitidis groups A, B, C, Y, W135
• Streptococcus agalactiae

Co-agglutination Technique

Bacteriology

DOCUMENTATION REQUIREMENT:Microbiology Request form (completely filled out)

SAMPLE COLLECTION INSTRUCTIONS(Clinicians):

1. Collect sample aseptically by lumbar puncture.
2. Sequentially collect CSF into minimum of 3 sterile tube or container (depends on tests).
3. Tube no. 2 will be submitted for bacteriology.
4. Label with Complete information on tube or container.
5. Submit to laboratory immediately
6. Do not refrigerate

Note:

1. Check the information before sending to HP Del Monte Laboratory.
2. Specimens in leaky containers will be processed, but notify Physician of possibility of contamination.

Sterile Container

2 mL Cerebrospinal Fluid (CSF)

Not applicable

2 Days

Not applicable

Not applicable

• Place samples in sterile container and store at (15°C~25°C) room temperature.
• Send sample immediately to HPD Del Monte for ship out within the day.

·                    Improperly collected CSF sample

·                    Quantity not sufficient

·                    Improperly labelled specimens

·                    Contaminated sample

·                    Improper collection container

Daily

8:00 PM

Routine: 6 hours after receipt of specimen/ arrival of messenger

STAT: 2  hours after receipt of specimen/ arrival of messenger

Negative

Immunological methods, such as co-agglutination, used for the identification of Haemophilus influenza, Streptococcus pneumoniae, Streptococcus agalactiae and Neisseria meningitidis, contains antibodies directed against the capsular antigens of the microorganisms. Therefore, those organisms not possessing a capsule are non-reactive.

Q: What is PHADEBAC?

A: PHADEBAC is a test based on co-agglutination technique that allows rapid direct identification of Streptococcus pneumoniae, Haemophilus influenza type b, Neisseria meningitidis and Streptococcus agalactiae (Strep B) in cerebrospinal fluid.

Q: When would I want this test?

A: When there is suspected bacterial meningitis

Q: What will it tell me?

A: It will give a rapid result for direct identification of the organisms that cause bacterial meningitis

Q: Why perform PHADEBAC testing?

A: Serological techniques such as countercurrent immunoelectrophoresis (CIE) and immunofluorescence as tools for diagnosis of bacterial meningitis require experienced personnel and specially equipped laboratories. PHADEBACT will help and allow rapid direct identification, using simple slide technique

Not applicable

Not applicable

Not applicable

Screening test for sensitisation to the most common airborne allergens. Well correlated (approximately 95%) with clinical respiratory allergy diagnosis. First-line test to be used; the result must always be compared to the clinical diagnosis.

Fluorescent enzyme-immunoassay

Special Test

No patient preparation necessary.

Red or Gold Tube

3 mL Serum

Not Applicable

7 Days

14 Days

30 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch Running

Friday 4:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Not applicable

Allergy screening test, Inhalant Allergy

• Donnatal
• Luminal
• Quandrinal

Not applicable

Quantitative measurement of phenobarbital, an anticonvulsant and sedative-hypnotic drug, in human serum and plasma. The measurements obtained are used in the diagnosis and treatment of phenobarbital overdose and in monitoring levels of phenobarbital to help ensure appropriate therapy. Phenobarbital is used to control seizures, anxiety and prevent withdrawal symptoms in people who are dependent on another barbiturate medication and are going to stop taking the medication. It works by slowing activity in the brain.

Chemiluminescent Microparticle Immunoassay (CMIA)

Immunology

• Collect as trough specimen (generally 30 minutes before the next dose) unless specified by the requesting physician.
• Provide date and time of last Phenobarbital intake and sample collection. This information is important to help requesting clinicians interpret the result.

Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator)

1-3 mL Serum
 

1-3 mL Plasma (Li-heparin, K-EDTA, Na-heparin, Na-EDTA, K-oxalate)

2 Days

8 Days

6 Months

Transport specimen at 2°C – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Specimen stored/transported outside the temperature range
• Quantity not sufficient
• Improperly labeled specimens

Tuesday, Friday

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

ROUTINE (on running days)
• 4 hours after receipt of specimen/ arrival of messenger
STAT (on running days only)
• 2½ hours from extraction/messenger arrival

64.65-172.40 umol/L

• Amobarbital and mephobarbital are drugs structurally similar with phenobarbital. These drug may interfer in this assay.
• Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies. Such specimen may show either falsely elevated or depressed values when tested with assay that employ mouse monoclonal antibodies.
• Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. The presence of heterophilic antibodies in a patient specimen may cause anomalous values to be observed.

Not applicable

TDM, Therapeutic Drug Monitoring, Anti convulsant

• Dilantin
• Hydantoin

Not applicable

Used in monitoring levels of phenytoin to help ensure appropriate therapy. Phenytoin is used to control certain type of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Chemiluminescent Microparticle Immunoassay (CMIA)

Immunology

• Collect as trough specimen (generally 30 minutes before the next dose) unless specified by the requesting physician.
• For patients receiving FOSPHENYTOIN therapy, collect sample at least 2 hours after IV infusion or at least 4 hours after IM injection.
• Provide date and time of last Phenytoin intake and sample collection. This information is important to help requesting clinicians interpret the result.

Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator)

1-3 mL Serum
 

1-3 mL Plasma (Li-Heparin, K-EDTA, Na-citrate, Na-Heparin, Na-EDTA, K-Oxalate)

2 Days

8 Days

5 Months (5 Freeze-Thaw cycles)

Transport specimen at 2°C – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Specimen stored/transported outside the temperature range
• Quantity not sufficient
• Improperly labeled specimens

Tuesday, Friday

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

ROUTINE (on running days)
• 4 hours after receipt of specimen/ arrival of messenger
STAT (on running days only)
• 2½ hours from extraction/messenger arrival

39.60-79.20 umol/L

• Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (HAMA). Such specimens may show either falsely elevated or depressed values when tested with assay kits that employ mouse monoclonal antibodies.
• Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. The presence of heterophilic antibodies in a patient specimen may cause anomalous values to be observed.

Not applicable

TDM, Therapeutic Drug Monitoring, Anti convulsant

Phosphatidylserine Abs 

• Phosphatidylserine IgA

• Phosphatidylserine IgG

• Phosphatidylserine IgM

The presence of phossphatidylserine antibodies may be associated with thrombosis, fetal loss and thrombocytoprnia.

Enzyme Immunoassay (EIA)

Special Test

No patient preparation

• 1 mL platelet-poor plasma collected in a 3.2% sodium citrate (light-blue top) tube or serum

• Gold Tube

• 1 mL platelet-poor plasma collected in a 3.2% sodium citrate (light-blue top) tube or serum

•  2 mL Serum 

7 Days

21 Days

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch Running

Monday, 12:00 PM

14 working days after cut-off (excluding Saturdays, Sundays and Holidays)

Phosphatidylserine Ab IgG

Phosphatidylserine Ab IgA

Phosphatidylserine Ab IgM

None specified.

Not applicable